APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases
Artur Shvetcov(The University of Sydney), Caitlin A. Finney(Westmead Institute for Medical Research), Erik C. B. Johnson(Emory University), Heather Wilkins(University of Kansas Medical Center), Russell H. Swerdlow(University of Kansas), Terri G. Thompson(LightPointe (United States)), Jeffrey M. Burns(University of Kansas), Farhad Imam(BioVentures (United States)), Keenan A. Walker(National Institute on Aging), Jeffrey D. Rothstein(Johns Hopkins University), Laura Winchester(University of Oxford), Varsha Krish(Gates (United States)), Chad Slawson(University of Kansas Medical Center)
Cited by 56
Related Papers
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
|Nature Reviews Drug Discovery|2020|982
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
|Nature Neuroscience|2022|598
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids
|Nature Genetics|2011|578
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
|Trends in Biochemical Sciences|2010|341